Skip to content

A clinical trial study on the effect of perampanel on the prognosis of patients with traumatic brain injury

A clinical trial study on the effect of perampanel on the prognosis of patients with traumatic brain injury

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055423
Enrollment
Unknown
Registered
2022-01-09
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

Group 2:Placebo
Group 1:Perampanel treatment

Sponsors

The 904th Hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years, male or non-pregnant female; 2. A clear history of the first and acute craniocerebral trauma, and the head CT scan is a traumatic brain injury; 3. Before the start of the study, the patients or their families signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. There are contraindications to the use of perampanel; 2. There are serious primary diseases such as heart, liver, kidney, etc.; 3. Accompanied by severe multiple injuries; 4. Pregnancy and lactation; 5. Unable to cooperate with the test procedure due to mental illness; 6. Participated in other clinical trials within three months; 7. The researcher believes that it is not suitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Glasgow Prognostic Score;Glasgow Coma Index;Cognitive function assessment;Activities of Daily Living Scale;

Secondary

MeasureTime frame
30-day mortality;The incidence of epilepsy;Incidence of complications;Cerebral blood flow;Intracranial pressure;

Countries

China

Contacts

Public ContactYang Likun

The 904th Hospital of PLA

beck_yang@163.com+86 13915324321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026